Effect of Fermented Protaetia Brevitarsis Seulensis Powder on Alcohol-induced Liver Disease

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age19+
SponsorPusan National University Yangsan Hospital

About this trial

The investigators conduct a randomized, double-blind, placebo-controlled study to investigate the effects of Fermented Protaetia brevitarsis seulensis powder on Alcohol-induced Liver Disease in adults for 8 weeks.

Eligibility criteria

Qualifiers

Gamma-glutamyl transferase ranging from upper limit of reference to four times of upper limit

Disqualifiers

Abnormal liver or renal function (i.e., serum aminotransferase activity > 3 times of upper limit of reference range and serum creatinine concentrations > 1.2 mg/dL)

Diabetes (diagnosed clinically or fasting glucose level > 126 mg/dL)

History of viral hepatitis or cancer

Uncontrolled hypertension

Trial design

Treatments tested in this trial

  • Fermented Protaetia brevitarsis seulensis powder group
  • Placebo group

Treatment groups

30 Participants
are divided into 2 treatment groups